MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-KR-03-0010485
Sami Nutraceuticals Private Limited - pharma in Bengaluru, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹18 Cr
▼ 80.88% YoY
Net loss · FY 2025
₹32.11 Cr
Net margin -178.4%
EBITDA · FY 2025
-₹7.29 Cr
EBITDA margin -40.5%
Authorised capital
₹150 Cr
Registered with MCA
Paid-up capital
₹50 Cr
Issued & subscribed
Open charges
₹155 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
80
Provident fund records
About Sami Nutraceuticals Private Limited
Data last updated:
Sami Nutraceuticals Private Limited is a private limited company based in Bengaluru, Karnataka, India, a subsidiary of Sami-Sabinsa Group Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 April 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U15490KA2020PTC133889. Its GSTIN is 29ABDCS6349F1Z1 (Karnataka).
The company has an authorised share capital of ₹150 Cr and a paid-up capital of ₹50 Cr. It is led by directors including Shaheen Muhammed Majeed (Managing Director) and Anju Majeed.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 19/1&19/2 Peenya Industrial Area II Phase Chokkasandra Village, Bengaluru, Karnataka, India – 560058.
As per the financials filed for FY 2025, the company reported a revenue of ₹18 Cr. For the same year it recorded a net loss of ₹32.11 Cr (net margin -178.4%) and EBITDA of -₹7.29 Cr (EBITDA margin -40.5%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years.
The company has about 80 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹155 Cr on record.
Sami Nutraceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0010485). For more details, the company can be reached via its website sami-sabinsagroup.com.
Company details
CIN U15490KA2020PTC133889
Registration Number 133889
Incorporation Date 24 April 2020
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Sami-Sabinsa Group Limited
MSME Classification Medium
Udyam Registration UDYAM-KR-03-0010485
Recognitions & Rankings of Sami Nutraceuticals
Contact details
Sami Nutraceuticals Private Limited's registered office is in Bengaluru, Karnataka. Its website is sami-sabinsagroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address19/1&19/2 Peenya Industrial Area II Phase Chokkasandra Village, Bengaluru, Karnataka, India – 560058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sami Nutraceuticals Private Limited, buy the company report.
Comprehensive company report
Sami Nutraceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sami Nutraceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sami Nutraceuticals Private Limited, buy the company report.
Financials of Sami Nutraceuticals Private Limited
FY 2025 filings availableSami Nutraceuticals Private Limited reported revenue of ₹18 Cr for FY 2025.
Revenue · FY 2025
₹18 Cr
Net loss · FY 2025
₹32.11 Cr margin -178.4%
EBITDA · FY 2025
-₹7.29 Cr margin -40.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▼ 41%
Revenue has grown at a compounded annual rate (CAGR) of 18% over three years. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7.29 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹32.11 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -40.5% | ||||
| Net Profit Margin | -178.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sami Nutraceuticals Private Limited, buy the company report.
Board of directors and KMP of Sami Nutraceuticals Private Limited
Sami Nutraceuticals Private Limited currently reports 3 directors and 1 key managerial person. 6 former directors have served the organization.
Current Directors and KMP
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anju Majeed Also directs: Anjumana Properties LLP, Organica Aromatics Private Limited, Anjumana Private Limited and 5 more | Director | 24 Apr 2020 | 6 Years 5 Months | Current |
| Benny Thomas | Cfo | 27 Jan 2026 | 0 Years 8 Months | Current |
| Nagarajan Muthukaman Also directs: Organica Aromatics Private Limited, Sami Direct Marketing Private Limited, Sami-Sabinsa Group Limited and 2 more | Director | 30 Sep 2024 | 2 Years 0 Months | Current |
| Shaheen Muhammed Majeed Also directs: Organica Aromatics Private Limited, Sami-Sabinsa Group Limited, SJN Realty Private Limited and 1 more | Managing Director | 30 Mar 2024 | 2 Years 6 Months | Current |
Peer comparison
Sami Nutraceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers, Nutraceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anamayee Pharmachem Private Limited | ₹18.45 Cr (FY 2015) | -33.0% | Goa, India | |||
| Magma Industries Limited | ₹18.33 Cr (FY 2025) | -63.0% | Muzaffarnagar, Uttar Pradesh, India | |||
| Sami Nutraceuticals Private Limitedthis company | ₹18 Cr (FY 2025) | -₹32.11 Cr | -178.4% | 80 | Bengaluru, Karnataka, India | |
| Maksons Fine Chem Private Limited | ₹17.53 Cr (FY 2024) | -4.0% | Ankleshwar, Gujarat, India | |||
| Karnataka Nutraceuticals India Limited | ₹17.53 Cr (FY 2017) | 187.0% | Bangalore, Karnataka, India | |||
| Shriya Chemicals Pvt Ltd | ₹17.35 Cr (FY 2015) | -29.0% | Navi Mumbai, Maharashtra, India | |||
| Apionex Pharma Private Limited | ₹17.29 Cr (FY 2024) | 5.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Sami Nutraceuticals Private Limited, buy the company report.
Auditor
Sami Nutraceuticals Private Limited is audited by VARMA & VARMA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VARMA & VARMA | FY 2023 | 004532S |
Shareholding
The shareholding of Sami Nutraceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sami Nutraceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹155 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 May 2025 | 101105084 | Hdfc Bank Limited | ₹10 Cr | Open | |
| 28 Aug 2020 | 100373016 | Hdfc Bank Limited | ₹145 Cr | Open |
To see the full charge records of Sami Nutraceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Sami Nutraceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Sami Nutraceuticals Private Limited was last rated by Care on 24 Jan 2023.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 24 Jan 2023 |
To see the full credit ratings and regulatory alerts of Sami Nutraceuticals Private Limited, buy the company report.
MSME payment delays
Sami Nutraceuticals Private Limited has 4 MSME Form 1 returns on record between 2022 and 2023, listing 48 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Centpro Engineering Private Limited | |||
| an individual supplier | |||
| Acme Process Systems Private Limited | |||
| Geo Engineering Co Private Limited |
To see the full MSME payment records of Sami Nutraceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Sami Nutraceuticals Private Limited has a workforce of 80 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
Employee count
80
Active EPFO establishments
1
Employee growth
56.86%
GST
Sami Nutraceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29ABDCS6349F1Z1 | Karnataka | Active | 23 Jun 2020 |
To see the full GST registrations and return filing status of Sami Nutraceuticals Private Limited, buy the company report.
Recent activity
Sami Nutraceuticals Private Limited has 14 board changes on record since 2020: 9 appointments and 5 cessations. The latest: Benny Thomas was appointed as CFO on 27 Jan 2026.
Appointed
Benny Thomas was appointed as CFO.
AGM
Sami Nutraceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 101105084 was registered on 20 May 2025.
Filing
Sami Nutraceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Nagarajan Muthukaman was appointed as Director.
Ceased
Syed Saleel ceased to be Director.
Appointed
Shaheen Muhammed Majeed was appointed as Managing Director.
Ceased
Muhammed Majeed ceased to be Director.
Appointed
Syed Saleel was appointed as Director.
Ceased
Ramana Rao Chebolu ceased to be Company Secretary.
Ceased
Madhu Subramanian ceased to be Director.
Ceased
Neeraja Shantaram Shetty ceased to be Director.
8 earlier events are in the company report.
Frequently asked questions
Sami Nutraceuticals is an active private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 April 2020 (6+ years old) and is registered under CIN U15490KA2020PTC133889.
Sami Nutraceuticals has 4 current directors and KMP:
- Shaheen Muhammed Majeed - Managing Director
- Anju Majeed - Director
- Nagarajan Muthukaman - Director
- Benny Thomas - Cfo
The latest financial statements of Sami Nutraceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Sami Nutraceuticals is 29ABDCS6349F1Z1, registered in Karnataka.
The CIN (Corporate Identification Number) of Sami Nutraceuticals is U15490KA2020PTC133889. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sami Nutraceuticals was incorporated on 24 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Sami Nutraceuticals by revenue are Anamayee Pharmachem Private Limited, Magma Industries Limited, Maksons Fine Chem Private Limited, Karnataka Nutraceuticals India Limited, Shriya Chemicals Pvt Ltd and 1 more, all in the Pharma industry (API Manufacturers, Nutraceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Benny Thomas was appointed as CFO on 27 Jan 2026. Nagarajan Muthukaman was appointed as Director on 30 Sep 2024. Syed Saleel ceased to be Director on 26 Jun 2024. Sami Nutraceuticals has 14 board changes on record in total.
Yes, Sami Nutraceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-03-0010485).
Sami Nutraceuticals has 4 MSME Form 1 returns on record between 2022 and 2023, listing 48 overdue payments to 4 micro and small suppliers. The latest return was filed on 16 Oct 2023.
Sami Nutraceuticals can be reached through the website sami-sabinsagroup.com. Its registered office is in Bengaluru, Karnataka, India.
The registered office of Sami Nutraceuticals is at 191&192 Peenya Industrial Area II Phase Chokkasandra Village, Bengaluru, Karnataka, India – 560058.